During the forecast period, an increase in opioid overdose instances is anticipated to fuel demand for naloxone products used in emergency treatments for narcotic overdose. For instance, the U.S. Department of Health and Human Services (HHS) reported that, in 2019, 9.7 million adults over the age of 12 misused prescription painkillers in the U.S., or 3.7% of the country's population. This figure is based on data from the HHS.
The market for Naloxone in the United States is predicted to reach a value of US$ 1,390.7 million in 2022 and grow at a CAGR of 10.2% from 2022 to 2030.
Leading Companies in the U.S. Naloxone Industry:
1. Mylan N.V.: Created to satisfy the rising need for potent medications, generic pharmaceutical goods are developed and manufactured. Built in 1961. With its corporate headquarters in the United Kingdom, Mylan and Upjohn, a division of Pfizer, will merge to become a new champion for global health that is specially positioned to meet the demand for medicine around the globe.
2. Novartis AG: Innovative Medicines and Sandoz are two business sectors under which Novartis develops and produces healthcare goods. company Innovative pharmaceuticals sector, which includes international business franchises in oncology, ophthalmology, neurology, immunology, respiratory, cardio-metabolic, and established pharmaceuticals, accounts for the vast bulk of company revenue. Founded in 1996. Novartis successfully acquires The Medicines Company, adding the investigational cholesterol-lowering drug inclisiran, which may be a first-in-class treatment.
3. Indivior Plc.: A manufacturer of both specialised and generic medications is Indivior PLC. The company's primary business is the discovery, production, and distribution of prescription medications for the treatment of opioid dependence that are based on buprenorphine. The United States generates the great bulk of Indivior's revenue, followed by the rest of the world. Founded in 1994. Headqurtered at the U.S.
4. ADAPT Pharma, Inc.: Developer of medical patients' therapeutic procedures. The business helps its clients get access to the best care possible at the right moment by offering state-of-the-art novel treatment alternatives in the area of opioid overdose and addiction. Established in 2014. Headquarters in Dublin 2, Ireland, at 45 Fitzwilliam Square.
5. Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Inc. is a biopharmaceutical firm that specialises in creating, producing, marketing, and dispensing injectable, inhalation, and intranasal medications that are both generic and proprietary and that require complex technological processes. Founded in 1996. United States headquarters.
6. INSYS Therapeutics, Inc.: A specialised pharmaceutical company is Insys Therapeutics Inc. It creates and markets novel medications, unique drug delivery technologies, and therapeutic compounds that enhance the quality of life for patients. Built in 1998. U.S. headquarters are in Chandler.
*Definition: Naloxone is a medication approved by the Food and Drug Administration (FDA) designed to rapidly reverse opioid overdose.
